课题基金 / 基金详情

Evaluation of pain experience in domestic fowl: associations between clinical symptoms biochemical markers and bird self-selection of analgesics

Evaluation of pain experience in domestic fowl: associations between clinical symptoms biochemical markers and bird self-selection of analgesics
家禽疼痛体验的评估:临床症状生化标志物与家禽自我选择镇痛药之间的关联
批准号:
BB/G002738/1
负责人:
Susan Fleetwood-Walker
金额:
$20.44万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Experience of pain causes unpleasant subjective feelings in humans and may do so in animals. To reduce animal suffering, we need to be able to assess the severity and duration of experienced pain. Current methods for pain assessment, based on animal behaviour and the effect of analgesics, are difficult to interpret: additional information is required to assess whether experiences which appear to be painful are actually experienced as such. In humans, Patient Controlled Analgesia for pain management is a widely accepted procedure as it is clearly motivated by subjective states of pain perception and is used as one of the 'gold standards' for the assessment of conscious experience of pain in man. A demonstration that animals could make complex decisions to manage their own pain would provide important new information on their pain experience, as decision-making itself takes place in higher centres in the brain, thought to be involved in the generation of conscious experience. Studies of animal decision-making have been applied only sporadically to the question of animal pain. We propose to develop methodology in this area and to investigate whether levels of the neurotransmitter dynorphin change due to pain experience. Interpretation of the results of the few studies of self-selection of analgesics in animals is problematic. We developed a pilot method for studying self-selection of analgesic drugs, presented in food, to broiler chickens but this needs development and refinement. Our pilot results suggested that lame birds ate more drug-treated feed than sound birds. However, interpretation of the pilot results in terms of pain experience was complicated by changes in the level of lameness of birds over the duration of the experiment, the voracious appetites of broilers, similar end-stage plasma analgesic levels in lame and sound birds, and uncertainties relating to effective dose. We propose to advance this area of science by studying two well-defined clinical problems in birds, lameness in broiler chickens and bone fractures in laying hens. Both of these conditions are widespread in commerical agriculture and, if they are accompanied by pain, they represent a significant animal welfare problem. We have selected two conditions because different conditions may cause different 'types' of pain, leading to varying patterns of analgesic selection. We also wish to compare the ability to self-select analgesia in immature (broilers) and mature (hens) domestic fowl. By conducting detailed longitudinal studies, we aim to obtain new information on changes in analgesic intake over time, the effects on behaviour and mobility of analgesic intake, and the relationship between changes in behaviour, clinical signs and levels of drug detected in the blood and tissues. We will develop our pilot protocol by carrying out initial studies and modifying the method used in the self-selection study. First, we will develop methods to track the changes in putative pain experience using several advanced methods available in other species and several novel methods, including advanced imaging techniques. Nerve tissue samples from birds from 'in pain' and 'pain free' groups thus identified will be assayed for dynorphin. Next, we will examine a range of modes of drug presentation, so that drug selection is not necessarily confounded with appetite. Then, we will assess how the level of the analgesic drugs used is associated with drug concentration in blood and in relevant tissues. Changes in clinical signs and in pain behaviour will be monitored in parallel. This will help us to know whether the blood levels of analgesics found in the final self-selection trials are likely to provide effective pain relief. Finally, using appropriate controls, we will assess whether domestic chickens reliably select analgesics when given the opportunity. This will enable us to assess the welfare impact of lameness and bone fractures in chickens.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
2. Enhanced transient receptor potential channel expression and activation by endogenous mediators in lame broiler chickens (in preparation).
2.内源性介质增强跛行肉鸡瞬时受体电位通道的表达和激活(准备中)。
DOI: --
发表时间:
期刊: Neuroscience
影响因子: 3.3
作者: [Jerina, H]
通讯作者: Jerina, H
Pain-associated changes in the dorsal root ganglia of laminitic horses
蹄纹马背根神经节的疼痛相关变化
DOI: 10.1016/j.jevs.2013.08.054
发表时间: 2013
期刊: Journal of Equine Veterinary Science
影响因子: 1.3
作者: [Gauff F]
通讯作者: Gauff F
1. Elevated nociceptive biomarker levels in chickens with a spontaneously-occurring pain state: keel-bone fractures in laying hens (in preparation).
1. 具有自发性疼痛状态的鸡的伤害性生物标志物水平升高:产蛋鸡的龙骨骨折(准备中)。
DOI: --
发表时间:
期刊: Brain Research
影响因子: 2.9
作者: [Jerina, H]
通讯作者: Jerina, H
DOI: 10.1200/jco.2015.63.8221
发表时间: 2016-02-20
期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子: --
作者: [Fallon M, Hoskin PJ, Colvin LA, Fleetwood-Walker SM, Adamson D, Byrne A, Murray GD, Laird BJ]
通讯作者: Laird BJ
7
    国内基金
    海外基金
    脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
    • 批准号:
      82371223
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      闻大翔
    • 依托单位:
    弓状核介导慢性疼痛引起动机下降的神经环路机制及rTMS干预研究
    • 批准号:
      82371536
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张松
    • 依托单位:
    NCAM参与GDNF缓解CCI大鼠疼痛的机制研究
    • 批准号:
      30901402
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2009
    • 负责人:
      王红军
    • 依托单位:
    CaMK II信号转导通路参与前扣带回皮质调节IBS大鼠的内脏痛觉
    • 批准号:
      30800512
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      19.0万元
    • 批准年份:
      2008
    • 负责人:
      曹芝君
    • 依托单位: